tirzepatide lab GLP-2 TZ – True Peptides Tirzepatide Dual Agonist (GLP-1/GIP) |

The FDA label for Zepbound carries a black-box warning against use in patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2

PlexusDx's Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptides, including these key variants, to predict how your body will respond to tirzepatide therapy

Step 2: choose your anchor time Morning or evening, based on your side effect profile and daily routine

Greater HbA1c Reduction: TZP delivers more significant reductions in HbA1c, particularly beneficial for patients with stubborn hyperglycemia

increasing the dose too fast raises the risk of side effects

This approach maximizes initial results while minimizing long-term injection burden